BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 16142238)

  • 1. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells.
    Phan RT; Saito M; Basso K; Niu H; Dalla-Favera R
    Nat Immunol; 2005 Oct; 6(10):1054-60. PubMed ID: 16142238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
    Phan RT; Dalla-Favera R
    Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylation inactivates the transcriptional repressor BCL6.
    Bereshchenko OR; Gu W; Dalla-Favera R
    Nat Genet; 2002 Dec; 32(4):606-13. PubMed ID: 12402037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A-Miz-ing BCL6.
    Wu X; Jelinek DF
    Nat Immunol; 2005 Oct; 6(10):964-6. PubMed ID: 16177801
    [No Abstract]   [Full Text] [Related]  

  • 5. A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling.
    Shvarts A; Brummelkamp TR; Scheeren F; Koh E; Daley GQ; Spits H; Bernards R
    Genes Dev; 2002 Mar; 16(6):681-6. PubMed ID: 11914273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis.
    Basso K; Dalla-Favera R
    Adv Immunol; 2010; 105():193-210. PubMed ID: 20510734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis.
    Jardin F; Sahota SS
    Hematology; 2005 Apr; 10(2):115-29. PubMed ID: 16019457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter.
    Wu S; Cetinkaya C; Munoz-Alonso MJ; von der Lehr N; Bahram F; Beuger V; Eilers M; Leon J; Larsson LG
    Oncogene; 2003 Jan; 22(3):351-60. PubMed ID: 12545156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of p15INK4b expression by Myc through association with Miz-1.
    Staller P; Peukert K; Kiermaier A; Seoane J; Lukas J; Karsunky H; Möröy T; Bartek J; Massagué J; Hänel F; Eilers M
    Nat Cell Biol; 2001 Apr; 3(4):392-9. PubMed ID: 11283613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional repressor BCL-6 immortalizes germinal center-like B cells in the absence of p53 function.
    Kusam S; Vasanwala FH; Dent AL
    Oncogene; 2004 Jan; 23(3):839-44. PubMed ID: 14737119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proto-oncogene BCL-6 in normal and malignant B cell development.
    Niu H
    Hematol Oncol; 2002 Dec; 20(4):155-66. PubMed ID: 12469325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition DNA sequence of a novel putative transcription factor, BCL6.
    Kawamata N; Miki T; Ohashi K; Suzuki K; Fukuda T; Hirosawa S; Aoki N
    Biochem Biophys Res Commun; 1994 Oct; 204(1):366-74. PubMed ID: 7945383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ARF tumor suppressor inhibits BCL6-mediated transcriptional repression.
    Suzuki H; Kurita M; Mizumoto K; Moriyama M; Aiso S; Nishimoto I; Matsuoka M
    Biochem Biophys Res Commun; 2005 Jan; 326(1):242-8. PubMed ID: 15567177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of negative regulatory regions within the first exon and intron of the BCL6 gene.
    Kikuchi M; Miki T; Kumagai T; Fukuda T; Kamiyama R; Miyasaka N; Hirosawa S
    Oncogene; 2000 Oct; 19(42):4941-5. PubMed ID: 11039912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.
    Baron BW; Anastasi J; Thirman MJ; Furukawa Y; Fears S; Kim DC; Simone F; Birkenbach M; Montag A; Sadhu A; Zeleznik-Le N; McKeithan TW
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2860-5. PubMed ID: 11854457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication foci.
    Albagli O; Lantoine D; Quief S; Quignon F; Englert C; Kerckaert JP; Montarras D; Pinset C; Lindon C
    Oncogene; 1999 Sep; 18(36):5063-75. PubMed ID: 10490843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaiso is a key regulator of spleen germinal center formation by repressing Bcl6 expression in splenocytes.
    Koh DI; Yoon JH; Kim MK; An H; Kim MY; Hur MW
    Biochem Biophys Res Commun; 2013 Dec; 442(3-4):177-82. PubMed ID: 24269670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A role for Bcl6 in immune memory development].
    Tokuhisa T
    Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2306-12. PubMed ID: 12518453
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6.
    Kurata M; Maesako Y; Ueda C; Nishikori M; Akasaka T; Uchiyama T; Ohno H
    Cancer Res; 2002 Nov; 62(21):6224-30. PubMed ID: 12414651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells.
    Niu H; Cattoretti G; Dalla-Favera R
    J Exp Med; 2003 Jul; 198(2):211-21. PubMed ID: 12860928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.